Roa WH - Search Results

1

Dosimetric predictors of toxicity in a randomized study of short-course vs conventional radiotherapy for glioblastoma.

Yang F, Dinakaran D, Heikal AA, Yaghoobpour Tari S, Ghosh S, Amanie J, Murtha A, Rowe LS, Roa WH, Patel S. Yang F, et al. Among authors: roa wh. Radiother Oncol. 2022 Dec;177:152-157. doi: 10.1016/j.radonc.2022.10.016. Epub 2022 Oct 20. Radiother Oncol. 2022. PMID: 36273738 Clinical Trial.

2

[No title available]

[No authors listed] [No authors listed] PMID: 34700516

3

Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer.

Holloway CL, Robinson D, Murray B, Amanie J, Butts C, Smylie M, Chu K, McEwan AJ, Halperin R, Roa WH. Holloway CL, et al. Among authors: roa wh. Radiother Oncol. 2004 Dec;73(3):285-7. doi: 10.1016/j.radonc.2004.07.033. Radiother Oncol. 2004. PMID: 15588872 Clinical Trial.

4

A Phase I Study of Tomotherapy in Patients With Primary Benign and Low-grade Brain Tumors: Late Toxicity and Quality of Life.

Boychak A, Bauman G, Fisher B, Abdulkarim B, Amanie J, Fulton D, Murtha A, Patel S, Urtasun R, Ghosh S, Roa WH. Boychak A, et al. Among authors: roa wh. Am J Clin Oncol. 2016 Apr;39(2):160-6. doi: 10.1097/COC.0000000000000034. Am J Clin Oncol. 2016. PMID: 24457533 Clinical Trial.

5

Improved cost-effectiveness of short-course radiotherapy in elderly and/or frail patients with glioblastoma.

Ghosh S, Baker S, de Castro DG, Kepka L, Kumar N, Sinaika V, Matiello J, Lomidze D, Dyttus-Cebulok K, Rosenblatt E, Fidarova E, Roa W. Ghosh S, et al. Radiother Oncol. 2018 Apr;127(1):114-120. doi: 10.1016/j.radonc.2018.01.017. Epub 2018 Feb 13. Radiother Oncol. 2018. PMID: 29452901 Clinical Trial.

6

Early Metabolic Changes in 1H-MRSI Predictive for Survival in Patients With Newly Diagnosed High-grade Glioma.

Wang MH, Roa W, Wachowicz K, Yahya A, Murtha A, Amanie J, Chainey J, Quon H, Ghosh S, Patel S. Wang MH, et al. Anticancer Res. 2022 May;42(5):2665-2673. doi: 10.21873/anticanres.15744. Anticancer Res. 2022. PMID: 35489774

7

Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.

Jastaniyah N, Murtha A, Pervez N, Le D, Roa W, Patel S, Mackenzie M, Fulton D, Field C, Ghosh S, Fallone G, Abdulkarim B. Jastaniyah N, et al. Radiat Oncol. 2013 Feb 20;8:38. doi: 10.1186/1748-717X-8-38. Radiat Oncol. 2013. PMID: 23425509 Free PMC article. Clinical Trial.

8

Reply to H. Kim et al and T. Finazzi.

Roa W, Ghosh S, Zhu Q, Baker S. Roa W, et al. J Clin Oncol. 2016 Jun 20;34(18):2192-3. doi: 10.1200/JCO.2016.66.7667. Epub 2016 Apr 11. J Clin Oncol. 2016. PMID: 27069079 No abstract available.

9

Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

Roa W, Brasher PM, Bauman G, Anthes M, Bruera E, Chan A, Fisher B, Fulton D, Gulavita S, Hao C, Husain S, Murtha A, Petruk K, Stewart D, Tai P, Urtasun R, Cairncross JG, Forsyth P. Roa W, et al. J Clin Oncol. 2004 May 1;22(9):1583-8. doi: 10.1200/JCO.2004.06.082. Epub 2004 Mar 29. J Clin Oncol. 2004. PMID: 15051755 Clinical Trial.

10

Changes in serial magnetic resonance spectroscopy predict outcome in high-grade glioma during and after postoperative radiotherapy.

Quon H, Brunet B, Alexander A, Murtha A, Abdulkarim B, Fulton D, Smerdely M, Johnson M, Urtasun R, Patel S, Ghosh S, Roa W. Quon H, et al. Anticancer Res. 2011 Oct;31(10):3559-65. Anticancer Res. 2011. PMID: 21965778 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page